Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial.

Eduard Shantsila,Farhan Shahid,Yongzhong Sun,Jonathan J Deeks,Melanie Calvert,James P. Fisher,Paulus Kirchhof,Paramjit Gill,Gregory Y.H. Lip

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial.

2020

Eduard Shantsila
Farhan Shahid
Yongzhong Sun
Jonathan J Deeks
Melanie Calvert
James P. Fisher
Paulus Kirchhof
Paramjit Gill
Gregory Y.H. Lip

Background Patients with permanent atrial fibrillation have poor outcomes, exercise capacity, and quality of life even on optimal anticoagulation. Based on mechanistic and observational data, we te...

Keywords:

Atrial fibrillation
Quality of life
Cardiology
exercise capacity
Heart failure
Observational study
Internal medicine
Randomized controlled trial
Spironolactone
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations